Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference
December 02 2021 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced that its Chief Science Officer Dr. Kristi
Snell will present during the Canola Week 2021 Conference taking
place in virtual format November 30 through December 2, 2021.
Dr. Snell will make a pre-recorded virtual presentation on
December 2, 2021 as part of Canola Innovation Day during the
session “Cutting Edge Molecular Technologies—Genome editing and
quantitative proteomics for Brassica crop improvement” scheduled
for 10:30 am - 11:30 am CST or 11:30 am -12:30 am EST. Her
presentation, entitled “Genome editing to increase seed oil in
Camelina,” will describe the use of CRISPR genome editing to
increase seed oil content in Camelina as well as the use of the
GRAIN platform to identify novel editing targets for oilseed
crops.
Yield10 researchers have identified and are currently developing
novel traits to increase seed oil content in oilseed crops. Line
E3902 was produced using CRISPR genome editing to modify three
genes in Camelina involved in oil biosynthesis and oil turnover.
The E3902 trait represents a leading trait in Yield10’s pipeline
and is currently being scaled up to produce oil for sampling.
Earlier in 2021, Yield10 announced the identification of the novel
trait C3020 and three additional traits which may be useful for
increasing oil content using the Company’s GRAIN platform.
Overexpression of C3020 in Camelina produced a ten percent increase
in seed oil content in greenhouse studies. Yield10 plans further
work with these novel oil content traits including the evaluation
of trait combinations.
“Demand for oil feedstock for production of renewable diesel in
the U.S. and Canada is expected to rise significantly over the next
five years,” said Kristi Snell, Ph.D., Chief Science Officer of
Yield10 Bioscience. “We believe that our GRAIN platform has enabled
us to identify valuable new traits to meaningfully increase oil
content in oil seed crops to meet the emerging growth in demand for
oil in biofuel applications. Our work in Camelina has the potential
to transform the crop into a high revenue, high yield, and low
carbon index crop for securing acreage to produce renewable diesel
feedstock.”
Learn more about the CanolaWeek 2021 conference on the
conference website. On Thursday, December 2, a copy of Dr. Snell’s
slide deck as well as a video of the presentation will be available
on the Yield10 Bioscience investor relations website.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company that
is using its differentiated trait gene discovery platform, the
“Trait Factory”, to develop improved Camelina varieties for the
production of proprietary seed products, and to discover high value
genetic traits for the agriculture and food industries. Our goals
are to efficiently establish a high value seed products business
based on developing superior varieties of Camelina to produce
feedstock oils, nutritional oils, and PHA bioplastics, and to
license our yield traits to major seed companies for
commercialization in major row crops, including corn, soybean and
canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds
Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for
Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, expectations related to research and development
activities, reproducibility of data from greenhouse and field
tests, market demand for the Company’s products, the signing of
research licenses and collaborations, including whether the
objectives of those collaborations will be met, as well as the
overall progress of Yield10 Bioscience, Inc., constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience's filings with the Securities and Exchange Commission.
Yield10 assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
matters described herein.
Contacts: Yield10 Bioscience:Lynne H. Brum,
(617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Sep 2023 to Sep 2024